2020-11-10

Teddy Lab and AstraZeneca China signed strategic MOU for the CDx development of HRD, the standardization of sequencing and commercialization to provide cancer patients precision diagnosis and treatment as one-stop service.

2020-10-22

ACT Genomics co-organizes the 7th Hong Kong International Oncology Symposium (HKIOS) to invite experts to share their first-hand experience with this groundbreaking advances in cancer management to speed up the progress of clinical practice.

2020-09-29

To provide better care for cancer patients in precision medicine, strategic cooperations among biotech and insurance company are on the rise. We are happy to announce that ACT Genomics cooperates with Nan Shan Life Insurance for precision medicine project

2020-09-28

Approximately 5–10% of cancers are caused by inherited genetic mutations, and through high-quality hereditary genetic test ACTRisk? , you and your family can start your hereditary medical plan better and earlier.

2020-09-07

ACT Genomics is pleased to announce the completion of the first closing of the latest round of equity financing from a group of strategic investors including Aflac Ventures LLC and Kyoto University Innovation Capital.

2020-06-20

ACT Genomics, Kaohsiung Medical University (KMU), and National Health Research Institutes (NHRI) launched a joint clinical research collaboration aimed to establish comprehensive genomic profiles of Melanoma within the Taiwanese population